nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—CYP1A2—Proguanil—malaria	0.104	0.251	CbGbCtD
Alitretinoin—CYP1A2—Pentoxifylline—malaria	0.0747	0.18	CbGbCtD
Alitretinoin—CYP1A2—Quinine—malaria	0.067	0.162	CbGbCtD
Alitretinoin—CYP1A2—Quinidine—malaria	0.0589	0.142	CbGbCtD
Alitretinoin—ABCB1—Quinine—malaria	0.0586	0.141	CbGbCtD
Alitretinoin—ABCB1—Quinidine—malaria	0.0515	0.124	CbGbCtD
Alitretinoin—CRABP1—hematopoietic system—malaria	0.00798	0.0797	CbGeAlD
Alitretinoin—RXRA—kidney—malaria	0.00589	0.0588	CbGeAlD
Alitretinoin—RARG—hematopoietic system—malaria	0.00526	0.0526	CbGeAlD
Alitretinoin—CRABP2—digestive system—malaria	0.00502	0.0501	CbGeAlD
Alitretinoin—RARA—hematopoietic system—malaria	0.00495	0.0495	CbGeAlD
Alitretinoin—CRABP2—blood—malaria	0.00478	0.0478	CbGeAlD
Alitretinoin—RARA—kidney—malaria	0.00406	0.0405	CbGeAlD
Alitretinoin—CRABP2—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00376	0.0519	CbGpPWpGaD
Alitretinoin—CRABP1—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00376	0.0519	CbGpPWpGaD
Alitretinoin—RXRA—liver—malaria	0.00372	0.0372	CbGeAlD
Alitretinoin—RARG—digestive system—malaria	0.00366	0.0366	CbGeAlD
Alitretinoin—RARG—blood—malaria	0.00349	0.0348	CbGeAlD
Alitretinoin—RARB—liver—malaria	0.00334	0.0334	CbGeAlD
Alitretinoin—CYP1A2—blood plasma—malaria	0.00332	0.0332	CbGeAlD
Alitretinoin—CRABP1—brain—malaria	0.00328	0.0328	CbGeAlD
Alitretinoin—RARA—blood—malaria	0.00328	0.0328	CbGeAlD
Alitretinoin—RARA—bone marrow—malaria	0.00317	0.0317	CbGeAlD
Alitretinoin—RXRB—liver—malaria	0.00307	0.0307	CbGeAlD
Alitretinoin—CRABP2—brain—malaria	0.00297	0.0296	CbGeAlD
Alitretinoin—RXRA—brain—malaria	0.00295	0.0295	CbGeAlD
Alitretinoin—RARB—brain—malaria	0.00265	0.0265	CbGeAlD
Alitretinoin—RXRG—brain—malaria	0.00259	0.0259	CbGeAlD
Alitretinoin—RARA—liver—malaria	0.00256	0.0256	CbGeAlD
Alitretinoin—RARG—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00254	0.0351	CbGpPWpGaD
Alitretinoin—RXRB—brain—malaria	0.00244	0.0244	CbGeAlD
Alitretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	0.00238	0.0328	CbGpPWpGaD
Alitretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	0.00238	0.0328	CbGpPWpGaD
Alitretinoin—CRABP1—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.00236	0.0326	CbGpPWpGaD
Alitretinoin—CRABP2—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.00236	0.0326	CbGpPWpGaD
Alitretinoin—RXRG—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00233	0.0321	CbGpPWpGaD
Alitretinoin—RARB—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00228	0.0314	CbGpPWpGaD
Alitretinoin—RARA—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00219	0.0302	CbGpPWpGaD
Alitretinoin—RXRB—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00219	0.0302	CbGpPWpGaD
Alitretinoin—RARG—brain—malaria	0.00216	0.0216	CbGeAlD
Alitretinoin—RARA—brain—malaria	0.00203	0.0203	CbGeAlD
Alitretinoin—CYP1A2—hematopoietic system—malaria	0.00183	0.0183	CbGeAlD
Alitretinoin—ABCB1—blood plasma—malaria	0.0017	0.017	CbGeAlD
Alitretinoin—RARG—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.0016	0.022	CbGpPWpGaD
Alitretinoin—RXRG—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.00146	0.0201	CbGpPWpGaD
Alitretinoin—RARB—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.00143	0.0197	CbGpPWpGaD
Alitretinoin—RARA—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.00137	0.0189	CbGpPWpGaD
Alitretinoin—RXRB—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.00137	0.0189	CbGpPWpGaD
Alitretinoin—CYP1A2—digestive system—malaria	0.00128	0.0128	CbGeAlD
Alitretinoin—CYP1A2—blood—malaria	0.00122	0.0121	CbGeAlD
Alitretinoin—RXRA—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00114	0.0157	CbGpPWpGaD
Alitretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—malaria	0.000974	0.0134	CbGpPWpGaD
Alitretinoin—CYP1A2—liver—malaria	0.00095	0.0095	CbGeAlD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000948	0.0131	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000948	0.0131	CbGpPWpGaD
Alitretinoin—ABCB1—hematopoietic system—malaria	0.00094	0.00939	CbGeAlD
Alitretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—malaria	0.000891	0.0123	CbGpPWpGaD
Alitretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—malaria	0.000874	0.012	CbGpPWpGaD
Alitretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—malaria	0.000838	0.0115	CbGpPWpGaD
Alitretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—malaria	0.000838	0.0115	CbGpPWpGaD
Alitretinoin—ABCB1—kidney—malaria	0.00077	0.0077	CbGeAlD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000754	0.0104	CbGpPWpGaD
Alitretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	0.000752	0.0104	CbGpPWpGaD
Alitretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	0.000752	0.0104	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000723	0.00996	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	0.000721	0.00994	CbGpPWpGaD
Alitretinoin—RXRA—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.000715	0.00986	CbGpPWpGaD
Alitretinoin—ABCB1—digestive system—malaria	0.000654	0.00653	CbGeAlD
Alitretinoin—ABCB1—blood—malaria	0.000623	0.00622	CbGeAlD
Alitretinoin—RXRA—NRF2 pathway—G6PD—malaria	0.000612	0.00844	CbGpPWpGaD
Alitretinoin—ABCB1—bone marrow—malaria	0.000603	0.00602	CbGeAlD
Alitretinoin—RXRG—Adipogenesis—FAS—malaria	0.000579	0.00798	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—FAS—malaria	0.000544	0.00751	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—DHODH—malaria	0.000528	0.00728	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—DHODH—malaria	0.000528	0.00728	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000519	0.00716	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000519	0.00716	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—malaria	0.000499	0.00688	CbGpPWpGaD
Alitretinoin—ABCB1—liver—malaria	0.000487	0.00487	CbGeAlD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000477	0.00658	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000477	0.00658	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—SLC4A1—malaria	0.000449	0.00619	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—SLC4A1—malaria	0.000449	0.00619	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—CD36—malaria	0.000449	0.00619	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000443	0.00107	CcSEcCtD
Alitretinoin—Urethral disorder—Quinidine barbiturate—malaria	0.000443	0.00107	CcSEcCtD
Alitretinoin—Insomnia—Sulfadiazine—malaria	0.00044	0.00107	CcSEcCtD
Alitretinoin—Mental disorder—Quinine—malaria	0.000438	0.00106	CcSEcCtD
Alitretinoin—Mental disorder—Quinidine—malaria	0.000438	0.00106	CcSEcCtD
Alitretinoin—Flatulence—Clindamycin—malaria	0.000438	0.00106	CcSEcCtD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—malaria	0.000437	0.00602	CbGpPWpGaD
Alitretinoin—Malnutrition—Quinine—malaria	0.000436	0.00106	CcSEcCtD
Alitretinoin—Erythema—Quinine—malaria	0.000436	0.00106	CcSEcCtD
Alitretinoin—Erythema—Quinidine—malaria	0.000436	0.00106	CcSEcCtD
Alitretinoin—Malnutrition—Quinidine—malaria	0.000436	0.00106	CcSEcCtD
Alitretinoin—Nausea—Proguanil—malaria	0.000436	0.00106	CcSEcCtD
Alitretinoin—Visual impairment—Quinidine barbiturate—malaria	0.000435	0.00105	CcSEcCtD
Alitretinoin—Vision blurred—Dapsone—malaria	0.000433	0.00105	CcSEcCtD
Alitretinoin—Back pain—Clindamycin—malaria	0.00043	0.00104	CcSEcCtD
Alitretinoin—Erythema multiforme—Quinidine barbiturate—malaria	0.000427	0.00103	CcSEcCtD
Alitretinoin—Decreased appetite—Sulfadiazine—malaria	0.000423	0.00103	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—DECR1—malaria	0.000422	0.00582	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—DECR1—malaria	0.000422	0.00582	CbGpPWpGaD
Alitretinoin—Eye disorder—Quinidine barbiturate—malaria	0.000422	0.00102	CcSEcCtD
Alitretinoin—Tinnitus—Quinidine barbiturate—malaria	0.000421	0.00102	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Sulfadiazine—malaria	0.00042	0.00102	CcSEcCtD
Alitretinoin—Flushing—Quinidine barbiturate—malaria	0.000419	0.00102	CcSEcCtD
Alitretinoin—Flushing—Pentoxifylline—malaria	0.000418	0.00101	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000417	0.00575	CbGpPWpGaD
Alitretinoin—Vision blurred—Quinidine—malaria	0.000411	0.000995	CcSEcCtD
Alitretinoin—Vision blurred—Quinine—malaria	0.000411	0.000995	CcSEcCtD
Alitretinoin—Anaemia—Clindamycin—malaria	0.00041	0.000995	CcSEcCtD
Alitretinoin—RXRA—Biological oxidations—HPGDS—malaria	0.000409	0.00565	CbGpPWpGaD
Alitretinoin—Tremor—Quinidine—malaria	0.000408	0.000989	CcSEcCtD
Alitretinoin—Tremor—Quinine—malaria	0.000408	0.000989	CcSEcCtD
Alitretinoin—Chills—Quinidine barbiturate—malaria	0.000405	0.000982	CcSEcCtD
Alitretinoin—Arrhythmia—Pentoxifylline—malaria	0.000403	0.000976	CcSEcCtD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—malaria	0.000403	0.00555	CbGpPWpGaD
Alitretinoin—Cough—Dapsone—malaria	0.000401	0.000971	CcSEcCtD
Alitretinoin—Agitation—Quinidine—malaria	0.0004	0.00097	CcSEcCtD
Alitretinoin—Agitation—Quinine—malaria	0.0004	0.00097	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.0004	0.00552	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Sulfadiazine—malaria	0.000398	0.000964	CcSEcCtD
Alitretinoin—Mental disorder—Quinidine barbiturate—malaria	0.000396	0.000959	CcSEcCtD
Alitretinoin—Malnutrition—Quinidine barbiturate—malaria	0.000393	0.000953	CcSEcCtD
Alitretinoin—Erythema—Quinidine barbiturate—malaria	0.000393	0.000953	CcSEcCtD
Alitretinoin—Erythema—Pentoxifylline—malaria	0.000392	0.000951	CcSEcCtD
Alitretinoin—Syncope—Quinine—malaria	0.000391	0.000947	CcSEcCtD
Alitretinoin—Syncope—Quinidine—malaria	0.000391	0.000947	CcSEcCtD
Alitretinoin—Flatulence—Pentoxifylline—malaria	0.000387	0.000937	CcSEcCtD
Alitretinoin—Urticaria—Sulfadiazine—malaria	0.000387	0.000937	CcSEcCtD
Alitretinoin—ABCB1—brain—malaria	0.000386	0.00386	CbGeAlD
Alitretinoin—Tension—Quinidine barbiturate—malaria	0.000386	0.000935	CcSEcCtD
Alitretinoin—Tension—Pentoxifylline—malaria	0.000385	0.000933	CcSEcCtD
Alitretinoin—Palpitations—Quinine—malaria	0.000385	0.000933	CcSEcCtD
Alitretinoin—Palpitations—Quinidine—malaria	0.000385	0.000933	CcSEcCtD
Alitretinoin—Body temperature increased—Sulfadiazine—malaria	0.000385	0.000932	CcSEcCtD
Alitretinoin—Abdominal pain—Sulfadiazine—malaria	0.000385	0.000932	CcSEcCtD
Alitretinoin—Hypertension—Clindamycin—malaria	0.000383	0.000929	CcSEcCtD
Alitretinoin—Loss of consciousness—Quinidine—malaria	0.000383	0.000928	CcSEcCtD
Alitretinoin—Loss of consciousness—Quinine—malaria	0.000383	0.000928	CcSEcCtD
Alitretinoin—Nervousness—Quinidine barbiturate—malaria	0.000382	0.000925	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—HBB—malaria	0.000382	0.00526	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—HBB—malaria	0.000382	0.00526	CbGpPWpGaD
Alitretinoin—Nervousness—Pentoxifylline—malaria	0.000381	0.000924	CcSEcCtD
Alitretinoin—Back pain—Pentoxifylline—malaria	0.00038	0.00092	CcSEcCtD
Alitretinoin—Convulsion—Quinidine—malaria	0.000377	0.000915	CcSEcCtD
Alitretinoin—Convulsion—Quinine—malaria	0.000377	0.000915	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000377	0.00519	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000375	0.00517	CbGpPWpGaD
Alitretinoin—Discomfort—Clindamycin—malaria	0.000374	0.000905	CcSEcCtD
Alitretinoin—Chest pain—Quinine—malaria	0.000371	0.000899	CcSEcCtD
Alitretinoin—Chest pain—Quinidine—malaria	0.000371	0.000899	CcSEcCtD
Alitretinoin—Myalgia—Quinine—malaria	0.000371	0.000899	CcSEcCtD
Alitretinoin—Myalgia—Quinidine—malaria	0.000371	0.000899	CcSEcCtD
Alitretinoin—Vision blurred—Quinidine barbiturate—malaria	0.000371	0.000898	CcSEcCtD
Alitretinoin—Vision blurred—Pentoxifylline—malaria	0.00037	0.000896	CcSEcCtD
Alitretinoin—Tremor—Quinidine barbiturate—malaria	0.000368	0.000893	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000368	0.000893	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000368	0.000893	CcSEcCtD
Alitretinoin—Tremor—Pentoxifylline—malaria	0.000368	0.000891	CcSEcCtD
Alitretinoin—Tachycardia—Dapsone—malaria	0.000366	0.000886	CcSEcCtD
Alitretinoin—Ill-defined disorder—Pentoxifylline—malaria	0.000364	0.000882	CcSEcCtD
Alitretinoin—Anaemia—Pentoxifylline—malaria	0.000363	0.000879	CcSEcCtD
Alitretinoin—Anaphylactic shock—Clindamycin—malaria	0.000362	0.000878	CcSEcCtD
Alitretinoin—Agitation—Quinidine barbiturate—malaria	0.000361	0.000876	CcSEcCtD
Alitretinoin—Agitation—Pentoxifylline—malaria	0.000361	0.000874	CcSEcCtD
Alitretinoin—Hypersensitivity—Sulfadiazine—malaria	0.000359	0.000869	CcSEcCtD
Alitretinoin—Confusional state—Quinine—malaria	0.000359	0.000869	CcSEcCtD
Alitretinoin—Confusional state—Quinidine—malaria	0.000359	0.000869	CcSEcCtD
Alitretinoin—Oedema—Quinidine—malaria	0.000356	0.000862	CcSEcCtD
Alitretinoin—Oedema—Quinine—malaria	0.000356	0.000862	CcSEcCtD
Alitretinoin—Thrombocytopenia—Clindamycin—malaria	0.000355	0.00086	CcSEcCtD
Alitretinoin—Malaise—Pentoxifylline—malaria	0.000354	0.000858	CcSEcCtD
Alitretinoin—Syncope—Quinidine barbiturate—malaria	0.000353	0.000854	CcSEcCtD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—HPGDS—malaria	0.000351	0.00484	CbGpPWpGaD
Alitretinoin—Shock—Quinine—malaria	0.00035	0.000848	CcSEcCtD
Alitretinoin—Shock—Quinidine—malaria	0.00035	0.000848	CcSEcCtD
Alitretinoin—Nervous system disorder—Quinidine—malaria	0.000349	0.000845	CcSEcCtD
Alitretinoin—Nervous system disorder—Quinine—malaria	0.000349	0.000845	CcSEcCtD
Alitretinoin—Thrombocytopenia—Quinine—malaria	0.000348	0.000844	CcSEcCtD
Alitretinoin—Thrombocytopenia—Quinidine—malaria	0.000348	0.000844	CcSEcCtD
Alitretinoin—Palpitations—Quinidine barbiturate—malaria	0.000347	0.000842	CcSEcCtD
Alitretinoin—Tachycardia—Quinidine—malaria	0.000347	0.000841	CcSEcCtD
Alitretinoin—Tachycardia—Quinine—malaria	0.000347	0.000841	CcSEcCtD
Alitretinoin—Palpitations—Pentoxifylline—malaria	0.000347	0.00084	CcSEcCtD
Alitretinoin—Loss of consciousness—Quinidine barbiturate—malaria	0.000346	0.000837	CcSEcCtD
Alitretinoin—Skin disorder—Quinidine—malaria	0.000345	0.000837	CcSEcCtD
Alitretinoin—Skin disorder—Quinine—malaria	0.000345	0.000837	CcSEcCtD
Alitretinoin—Pruritus—Sulfadiazine—malaria	0.000344	0.000834	CcSEcCtD
Alitretinoin—Hyperhidrosis—Quinidine—malaria	0.000344	0.000833	CcSEcCtD
Alitretinoin—Hyperhidrosis—Quinine—malaria	0.000344	0.000833	CcSEcCtD
Alitretinoin—Convulsion—Quinidine barbiturate—malaria	0.000341	0.000825	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—PKLR—malaria	0.00034	0.00469	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PKLR—malaria	0.00034	0.00469	CbGpPWpGaD
Alitretinoin—Convulsion—Pentoxifylline—malaria	0.00034	0.000824	CcSEcCtD
Alitretinoin—Anorexia—Quinidine—malaria	0.000339	0.000821	CcSEcCtD
Alitretinoin—Anorexia—Quinine—malaria	0.000339	0.000821	CcSEcCtD
Alitretinoin—Insomnia—Dapsone—malaria	0.000339	0.000821	CcSEcCtD
Alitretinoin—Hypertension—Pentoxifylline—malaria	0.000339	0.000821	CcSEcCtD
Alitretinoin—Hypotension—Clindamycin—malaria	0.000339	0.000821	CcSEcCtD
Alitretinoin—RXRA—PPARA activates gene expression—CD36—malaria	0.000337	0.00465	CbGpPWpGaD
Alitretinoin—Chest pain—Quinidine barbiturate—malaria	0.000335	0.000811	CcSEcCtD
Alitretinoin—Arthralgia—Quinidine barbiturate—malaria	0.000335	0.000811	CcSEcCtD
Alitretinoin—Myalgia—Quinidine barbiturate—malaria	0.000335	0.000811	CcSEcCtD
Alitretinoin—Chest pain—Pentoxifylline—malaria	0.000334	0.00081	CcSEcCtD
Alitretinoin—Myalgia—Pentoxifylline—malaria	0.000334	0.00081	CcSEcCtD
Alitretinoin—Anxiety—Quinidine barbiturate—malaria	0.000334	0.000808	CcSEcCtD
Alitretinoin—Diarrhoea—Sulfadiazine—malaria	0.000333	0.000807	CcSEcCtD
Alitretinoin—Anxiety—Pentoxifylline—malaria	0.000333	0.000807	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000332	0.000806	CcSEcCtD
Alitretinoin—Hypotension—Quinidine—malaria	0.000332	0.000805	CcSEcCtD
Alitretinoin—Hypotension—Quinine—malaria	0.000332	0.000805	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000332	0.000804	CcSEcCtD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—malaria	0.00033	0.00455	CbGpPWpGaD
Alitretinoin—Discomfort—Pentoxifylline—malaria	0.00033	0.0008	CcSEcCtD
Alitretinoin—Dry mouth—Pentoxifylline—malaria	0.000327	0.000792	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Quinidine—malaria	0.000324	0.000785	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Quinine—malaria	0.000324	0.000785	CcSEcCtD
Alitretinoin—Confusional state—Quinidine barbiturate—malaria	0.000324	0.000784	CcSEcCtD
Alitretinoin—Dyspnoea—Clindamycin—malaria	0.000323	0.000783	CcSEcCtD
Alitretinoin—Confusional state—Pentoxifylline—malaria	0.000323	0.000783	CcSEcCtD
Alitretinoin—Oedema—Quinidine barbiturate—malaria	0.000321	0.000778	CcSEcCtD
Alitretinoin—Oedema—Pentoxifylline—malaria	0.00032	0.000776	CcSEcCtD
Alitretinoin—Anaphylactic shock—Pentoxifylline—malaria	0.00032	0.000776	CcSEcCtD
Alitretinoin—Dyspepsia—Clindamycin—malaria	0.000319	0.000773	CcSEcCtD
Alitretinoin—Infection—Pentoxifylline—malaria	0.000318	0.000771	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000317	0.00437	CbGpPWpGaD
Alitretinoin—Dyspnoea—Quinidine—malaria	0.000317	0.000768	CcSEcCtD
Alitretinoin—Dyspnoea—Quinine—malaria	0.000317	0.000768	CcSEcCtD
Alitretinoin—Shock—Quinidine barbiturate—malaria	0.000316	0.000765	CcSEcCtD
Alitretinoin—Shock—Pentoxifylline—malaria	0.000315	0.000764	CcSEcCtD
Alitretinoin—Nervous system disorder—Quinidine barbiturate—malaria	0.000315	0.000763	CcSEcCtD
Alitretinoin—Thrombocytopenia—Quinidine barbiturate—malaria	0.000314	0.000761	CcSEcCtD
Alitretinoin—Thrombocytopenia—Pentoxifylline—malaria	0.000314	0.00076	CcSEcCtD
Alitretinoin—Tachycardia—Quinidine barbiturate—malaria	0.000313	0.000759	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Clindamycin—malaria	0.000313	0.000758	CcSEcCtD
Alitretinoin—Tachycardia—Pentoxifylline—malaria	0.000313	0.000758	CcSEcCtD
Alitretinoin—Fatigue—Clindamycin—malaria	0.000312	0.000757	CcSEcCtD
Alitretinoin—Skin disorder—Quinidine barbiturate—malaria	0.000312	0.000755	CcSEcCtD
Alitretinoin—Skin disorder—Pentoxifylline—malaria	0.000311	0.000754	CcSEcCtD
Alitretinoin—Hyperhidrosis—Quinidine barbiturate—malaria	0.00031	0.000752	CcSEcCtD
Alitretinoin—Pain—Clindamycin—malaria	0.00031	0.000751	CcSEcCtD
Alitretinoin—Constipation—Clindamycin—malaria	0.00031	0.000751	CcSEcCtD
Alitretinoin—Hyperhidrosis—Pentoxifylline—malaria	0.00031	0.00075	CcSEcCtD
Alitretinoin—Vomiting—Sulfadiazine—malaria	0.000309	0.00075	CcSEcCtD
Alitretinoin—Decreased appetite—Quinidine—malaria	0.000309	0.000749	CcSEcCtD
Alitretinoin—Decreased appetite—Quinine—malaria	0.000309	0.000749	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Quinidine—malaria	0.000307	0.000744	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Quinine—malaria	0.000307	0.000744	CcSEcCtD
Alitretinoin—Rash—Sulfadiazine—malaria	0.000307	0.000744	CcSEcCtD
Alitretinoin—Dermatitis—Sulfadiazine—malaria	0.000307	0.000743	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Dapsone—malaria	0.000306	0.000742	CcSEcCtD
Alitretinoin—Anorexia—Quinidine barbiturate—malaria	0.000306	0.000741	CcSEcCtD
Alitretinoin—Anorexia—Pentoxifylline—malaria	0.000305	0.00074	CcSEcCtD
Alitretinoin—Headache—Sulfadiazine—malaria	0.000305	0.000739	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—G6PD—malaria	0.000303	0.00418	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—G6PD—malaria	0.000303	0.00418	CbGpPWpGaD
Alitretinoin—Hypotension—Quinidine barbiturate—malaria	0.0003	0.000727	CcSEcCtD
Alitretinoin—Hypotension—Pentoxifylline—malaria	0.000299	0.000725	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—CD36—malaria	0.000299	0.00413	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—CD36—malaria	0.000299	0.00413	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Clindamycin—malaria	0.000296	0.000718	CcSEcCtD
Alitretinoin—Abdominal pain—Dapsone—malaria	0.000296	0.000718	CcSEcCtD
Alitretinoin—Body temperature increased—Dapsone—malaria	0.000296	0.000718	CcSEcCtD
Alitretinoin—Feeling abnormal—Quinine—malaria	0.000293	0.00071	CcSEcCtD
Alitretinoin—Feeling abnormal—Quinidine—malaria	0.000293	0.00071	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000292	0.000708	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000292	0.000707	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Quinidine—malaria	0.000291	0.000705	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Quinine—malaria	0.000291	0.000705	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC4A1—malaria	0.00029	0.004	CbGpPWpGaD
Alitretinoin—Insomnia—Pentoxifylline—malaria	0.00029	0.000702	CcSEcCtD
Alitretinoin—Nausea—Sulfadiazine—malaria	0.000289	0.000701	CcSEcCtD
Alitretinoin—Urticaria—Clindamycin—malaria	0.000288	0.000698	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000287	0.00396	CbGpPWpGaD
Alitretinoin—Body temperature increased—Clindamycin—malaria	0.000287	0.000694	CcSEcCtD
Alitretinoin—Abdominal pain—Clindamycin—malaria	0.000287	0.000694	CcSEcCtD
Alitretinoin—Dyspnoea—Quinidine barbiturate—malaria	0.000286	0.000693	CcSEcCtD
Alitretinoin—Dyspnoea—Pentoxifylline—malaria	0.000286	0.000692	CcSEcCtD
Alitretinoin—Somnolence—Quinidine barbiturate—malaria	0.000285	0.000691	CcSEcCtD
Alitretinoin—Somnolence—Pentoxifylline—malaria	0.000285	0.00069	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—FAS—malaria	0.000284	0.00391	CbGpPWpGaD
Alitretinoin—Urticaria—Quinidine—malaria	0.000282	0.000684	CcSEcCtD
Alitretinoin—Urticaria—Quinine—malaria	0.000282	0.000684	CcSEcCtD
Alitretinoin—Dyspepsia—Pentoxifylline—malaria	0.000282	0.000683	CcSEcCtD
Alitretinoin—Abdominal pain—Quinidine—malaria	0.000281	0.000681	CcSEcCtD
Alitretinoin—Body temperature increased—Quinine—malaria	0.000281	0.000681	CcSEcCtD
Alitretinoin—Abdominal pain—Quinine—malaria	0.000281	0.000681	CcSEcCtD
Alitretinoin—Body temperature increased—Quinidine—malaria	0.000281	0.000681	CcSEcCtD
Alitretinoin—Decreased appetite—Quinidine barbiturate—malaria	0.000279	0.000676	CcSEcCtD
Alitretinoin—Decreased appetite—Pentoxifylline—malaria	0.000278	0.000675	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000277	0.000671	CcSEcCtD
Alitretinoin—Pain—Quinidine barbiturate—malaria	0.000274	0.000665	CcSEcCtD
Alitretinoin—Constipation—Quinidine barbiturate—malaria	0.000274	0.000665	CcSEcCtD
Alitretinoin—Constipation—Pentoxifylline—malaria	0.000274	0.000664	CcSEcCtD
Alitretinoin—Hypersensitivity—Clindamycin—malaria	0.000267	0.000647	CcSEcCtD
Alitretinoin—Feeling abnormal—Quinidine barbiturate—malaria	0.000264	0.000641	CcSEcCtD
Alitretinoin—Feeling abnormal—Pentoxifylline—malaria	0.000264	0.00064	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000262	0.000636	CcSEcCtD
Alitretinoin—Hypersensitivity—Quinidine—malaria	0.000262	0.000635	CcSEcCtD
Alitretinoin—Hypersensitivity—Quinine—malaria	0.000262	0.000635	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Pentoxifylline—malaria	0.000262	0.000635	CcSEcCtD
Alitretinoin—Asthenia—Clindamycin—malaria	0.00026	0.00063	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—PKLR—malaria	0.000259	0.00357	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL12B—malaria	0.000258	0.00355	CbGpPWpGaD
Alitretinoin—Pruritus—Clindamycin—malaria	0.000256	0.000621	CcSEcCtD
Alitretinoin—Asthenia—Quinine—malaria	0.000255	0.000618	CcSEcCtD
Alitretinoin—Asthenia—Quinidine—malaria	0.000255	0.000618	CcSEcCtD
Alitretinoin—Urticaria—Quinidine barbiturate—malaria	0.000255	0.000618	CcSEcCtD
Alitretinoin—Urticaria—Pentoxifylline—malaria	0.000254	0.000617	CcSEcCtD
Alitretinoin—Body temperature increased—Quinidine barbiturate—malaria	0.000254	0.000615	CcSEcCtD
Alitretinoin—Abdominal pain—Quinidine barbiturate—malaria	0.000254	0.000615	CcSEcCtD
Alitretinoin—Body temperature increased—Pentoxifylline—malaria	0.000253	0.000614	CcSEcCtD
Alitretinoin—Abdominal pain—Pentoxifylline—malaria	0.000253	0.000614	CcSEcCtD
Alitretinoin—Pruritus—Quinine—malaria	0.000252	0.00061	CcSEcCtD
Alitretinoin—Pruritus—Quinidine—malaria	0.000252	0.00061	CcSEcCtD
Alitretinoin—Diarrhoea—Clindamycin—malaria	0.000248	0.000601	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—TNF—malaria	0.000246	0.00339	CbGpPWpGaD
Alitretinoin—Diarrhoea—Quinine—malaria	0.000243	0.00059	CcSEcCtD
Alitretinoin—Diarrhoea—Quinidine—malaria	0.000243	0.00059	CcSEcCtD
Alitretinoin—Dizziness—Clindamycin—malaria	0.00024	0.000581	CcSEcCtD
Alitretinoin—Vomiting—Dapsone—malaria	0.000238	0.000577	CcSEcCtD
Alitretinoin—Hypersensitivity—Quinidine barbiturate—malaria	0.000236	0.000573	CcSEcCtD
Alitretinoin—Hypersensitivity—Pentoxifylline—malaria	0.000236	0.000572	CcSEcCtD
Alitretinoin—Dizziness—Quinine—malaria	0.000235	0.00057	CcSEcCtD
Alitretinoin—Dizziness—Quinidine—malaria	0.000235	0.00057	CcSEcCtD
Alitretinoin—Headache—Dapsone—malaria	0.000235	0.000569	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—HPGDS—malaria	0.000231	0.00319	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—HPGDS—malaria	0.000231	0.00319	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TNF—malaria	0.000231	0.00319	CbGpPWpGaD
Alitretinoin—Vomiting—Clindamycin—malaria	0.00023	0.000558	CcSEcCtD
Alitretinoin—Asthenia—Quinidine barbiturate—malaria	0.00023	0.000558	CcSEcCtD
Alitretinoin—Asthenia—Pentoxifylline—malaria	0.00023	0.000557	CcSEcCtD
Alitretinoin—Rash—Clindamycin—malaria	0.000229	0.000554	CcSEcCtD
Alitretinoin—Dermatitis—Clindamycin—malaria	0.000228	0.000553	CcSEcCtD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	0.000228	0.00314	CbGpPWpGaD
Alitretinoin—Headache—Clindamycin—malaria	0.000227	0.00055	CcSEcCtD
Alitretinoin—Pruritus—Quinidine barbiturate—malaria	0.000227	0.00055	CcSEcCtD
Alitretinoin—Pruritus—Pentoxifylline—malaria	0.000227	0.000549	CcSEcCtD
Alitretinoin—Vomiting—Quinine—malaria	0.000226	0.000548	CcSEcCtD
Alitretinoin—Vomiting—Quinidine—malaria	0.000226	0.000548	CcSEcCtD
Alitretinoin—Rash—Quinine—malaria	0.000224	0.000543	CcSEcCtD
Alitretinoin—Rash—Quinidine—malaria	0.000224	0.000543	CcSEcCtD
Alitretinoin—Dermatitis—Quinidine—malaria	0.000224	0.000543	CcSEcCtD
Alitretinoin—Dermatitis—Quinine—malaria	0.000224	0.000543	CcSEcCtD
Alitretinoin—CYP1A2—Phase II conjugation—HPGDS—malaria	0.000223	0.00308	CbGpPWpGaD
Alitretinoin—Headache—Quinidine—malaria	0.000223	0.00054	CcSEcCtD
Alitretinoin—Headache—Quinine—malaria	0.000223	0.00054	CcSEcCtD
Alitretinoin—Nausea—Dapsone—malaria	0.000223	0.000539	CcSEcCtD
Alitretinoin—Diarrhoea—Quinidine barbiturate—malaria	0.00022	0.000532	CcSEcCtD
Alitretinoin—Diarrhoea—Pentoxifylline—malaria	0.000219	0.000531	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—CD36—malaria	0.000216	0.00298	CbGpPWpGaD
Alitretinoin—Nausea—Clindamycin—malaria	0.000215	0.000522	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—DHFR—malaria	0.000215	0.00296	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—DHFR—malaria	0.000215	0.00296	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—SCARB1—malaria	0.000212	0.00293	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—SCARB1—malaria	0.000212	0.00293	CbGpPWpGaD
Alitretinoin—Dizziness—Quinidine barbiturate—malaria	0.000212	0.000514	CcSEcCtD
Alitretinoin—Dizziness—Pentoxifylline—malaria	0.000212	0.000513	CcSEcCtD
Alitretinoin—Nausea—Quinine—malaria	0.000211	0.000512	CcSEcCtD
Alitretinoin—Nausea—Quinidine—malaria	0.000211	0.000512	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000209	0.00288	CbGpPWpGaD
Alitretinoin—Vomiting—Quinidine barbiturate—malaria	0.000204	0.000494	CcSEcCtD
Alitretinoin—Vomiting—Pentoxifylline—malaria	0.000204	0.000493	CcSEcCtD
Alitretinoin—Rash—Quinidine barbiturate—malaria	0.000202	0.00049	CcSEcCtD
Alitretinoin—Dermatitis—Quinidine barbiturate—malaria	0.000202	0.00049	CcSEcCtD
Alitretinoin—Rash—Pentoxifylline—malaria	0.000202	0.000489	CcSEcCtD
Alitretinoin—Dermatitis—Pentoxifylline—malaria	0.000202	0.000489	CcSEcCtD
Alitretinoin—Headache—Quinidine barbiturate—malaria	0.000201	0.000487	CcSEcCtD
Alitretinoin—Headache—Pentoxifylline—malaria	0.000201	0.000486	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—IL6—malaria	0.000198	0.00274	CbGpPWpGaD
Alitretinoin—Nausea—Quinidine barbiturate—malaria	0.000191	0.000462	CcSEcCtD
Alitretinoin—Nausea—Pentoxifylline—malaria	0.00019	0.000461	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—IL10—malaria	0.000188	0.0026	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CD40LG—malaria	0.000188	0.0026	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—IL6—malaria	0.000187	0.00257	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL4—malaria	0.000183	0.00253	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—malaria	0.000183	0.00253	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-B—malaria	0.000179	0.00247	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—malaria	0.000177	0.00244	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—malaria	0.00017	0.00234	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—FAS—malaria	0.000169	0.00233	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	0.000167	0.0023	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—DHODH—malaria	0.00016	0.0022	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000157	0.00217	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.00015	0.00207	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000144	0.00199	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.000136	0.00188	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SLC4A1—malaria	0.000136	0.00187	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CD36—malaria	0.000133	0.00184	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CD36—malaria	0.000133	0.00184	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—HPGDS—malaria	0.000131	0.0018	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—DECR1—malaria	0.000128	0.00176	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	0.000122	0.00168	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	0.000121	0.00167	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—TNF—malaria	0.00012	0.00166	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	0.000116	0.0016	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HBB—malaria	0.000116	0.00159	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IFNG—malaria	0.000111	0.00153	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PKLR—malaria	0.000103	0.00142	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CD36—malaria	0.000101	0.0014	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL1B—malaria	9.88e-05	0.00136	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL2—malaria	9.84e-05	0.00136	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—IL6—malaria	9.72e-05	0.00134	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—G6PD—malaria	9.18e-05	0.00127	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	9.16e-05	0.00126	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CD36—malaria	9.06e-05	0.00125	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—malaria	8.85e-05	0.00122	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	8.82e-05	0.00122	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	8.82e-05	0.00122	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KDR—malaria	8.77e-05	0.00121	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	8.33e-05	0.00115	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TNF—malaria	7.17e-05	0.000989	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HPGDS—malaria	7e-05	0.000966	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—DHFR—malaria	6.5e-05	0.000896	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SCARB1—malaria	6.43e-05	0.000886	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—DHODH—malaria	6.39e-05	0.000881	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC4A1—malaria	5.43e-05	0.000749	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—DECR1—malaria	5.11e-05	0.000704	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—DHODH—malaria	5.1e-05	0.000703	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	5.02e-05	0.000692	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HBB—malaria	4.62e-05	0.000637	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	4.61e-05	0.000635	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC4A1—malaria	4.34e-05	0.000598	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—malaria	4.14e-05	0.000571	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PKLR—malaria	4.12e-05	0.000568	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—DECR1—malaria	4.08e-05	0.000562	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CD36—malaria	4.04e-05	0.000556	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HBB—malaria	3.69e-05	0.000508	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—G6PD—malaria	3.67e-05	0.000506	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	3.54e-05	0.000488	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—malaria	3.34e-05	0.000461	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PKLR—malaria	3.29e-05	0.000453	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—G6PD—malaria	2.93e-05	0.000404	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	2.89e-05	0.000399	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HPGDS—malaria	2.8e-05	0.000386	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—DHFR—malaria	2.6e-05	0.000358	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SCARB1—malaria	2.57e-05	0.000354	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HPGDS—malaria	2.23e-05	0.000308	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—DHFR—malaria	2.07e-05	0.000286	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SCARB1—malaria	2.05e-05	0.000283	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CD36—malaria	1.61e-05	0.000222	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CD36—malaria	1.29e-05	0.000177	CbGpPWpGaD
